A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P301) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 100 AND 200MG FOR THE TREATMENT OF ADHD IN CHILDREN

Category Primary study
JournalJOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Year 2019
This article has no abstract
Epistemonikos ID: 2579a7ded685dbdb53da150c183a39ecee2178c2
First added on: Feb 11, 2025